Recombinant Application Scope

Autoimmune Diseases and Inflammatory Conditions: Tumor necrosis factor (TNF) inhibitors, such as infliximab, are employed in treating rheumatoid arthritis and Crohn’s disease.
Blood Disorders: Erythropoietin stimulates red blood cell production in anemia patients, and clotting factors like recombinant Factor VIII are crucial for hemophilia treatment.
Cancer Therapy: Monoclonal antibodies, such as trastuzumab, target specific cancer cells, improving treatment outcomes.

Recombinant Characteristics

Ingredients: Active ingredients are recombinant proteins produced through genetic engineering techniques.
Properties: These proteins are designed to mimic or modulate natural biological processes, offering targeted therapeutic effects.
Specification: 10mg/0.5ml
Packaging Specification: Packaging is tailored to maintain the stability and sterility of the protein, often involving vials or pre-filled syringes.
Storage: Typically, recombinant protein drugs require refrigeration at 2°C to 8°C (36°F to 46°F) to preserve efficacy.
Expiry Date: The shelf life is determined based on stability studies; users should refer to the packaging for specific expiration information.
Executive Standard: Manufacturing and quality standards comply with regulatory guidelines, such as those from the FDA or EMA.
Approval Number: Each product is assigned a unique approval number by regulatory authorities upon approval.
Date of Revision: Information regarding revisions is typically found in the product’s prescribing information.
Manufacturer: Jazz Pharmaceuticals plc.

Dosage and Administration: Dosage regimens are specific to each drug and condition being treated. Administration routes include intravenous, subcutaneous, or intramuscular injections.
Adverse Reactions: Common side effects may include injection site reactions, allergic responses, or flu-like symptoms.
Contraindications: Contraindications depend on the specific drug and patient conditions; detailed information is provided in the prescribing information.
Precautions: Monitoring for efficacy and adverse effects is essential. Special considerations may be necessary for pregnant or breastfeeding women, pediatric, or geriatric populations.

Drug Interactions: Potential interactions vary among different recombinant protein drugs. Healthcare providers should review patient medication profiles to identify possible interactions.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.